| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1572-0241.2004.04148.X |
| P698 | PubMed publication ID | 15128354 |
| P50 | author | Jean-Frédéric Colombel | Q30248037 |
| Edward V Loftus | Q56065843 | ||
| William Jeffery Sandborn | Q64364605 | ||
| William J. Tremaine | Q64364678 | ||
| Cathy D. Schleck | Q114082044 | ||
| William Scott Harmsen | Q114105124 | ||
| Bruce G Wolff | Q114440635 | ||
| Tonia Young-Fadok | Q114440636 | ||
| P2093 | author name string | John H Pemberton | |
| P2860 | cites work | Rational dosing of azathioprine and 6-mercaptopurine | Q28362608 |
| Infliximab in the treatment of Crohn's disease: a user's guide for clinicians | Q35030557 | ||
| Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro | Q40783827 | ||
| Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications | Q44247087 | ||
| Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients | Q44532951 | ||
| Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients | Q45062041 | ||
| Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. | Q51296838 | ||
| Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease | Q57265459 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| patient | Q181600 | ||
| P304 | page(s) | 878-883 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy | |
| P478 | volume | 99 |
| Q26865009 | A review of the impact of biologics on surgical complications in Crohn's disease |
| Q37983558 | A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease |
| Q80966501 | Advances in medical therapy for Crohn's disease |
| Q37754695 | Advances in surgical approaches to Crohn's disease: minimally invasive surgery and biologic therapy. |
| Q34073191 | Adverse events in IBD: to stop or continue immune suppressant and biologic treatment |
| Q84145760 | Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience |
| Q36839274 | Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial |
| Q26783978 | Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper |
| Q91763764 | Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty |
| Q37998988 | Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis |
| Q42271558 | Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients |
| Q38179381 | Biologic therapy and surgery for crohn disease |
| Q38020037 | Biologic therapy in psoriasis: perspectives on associated risks and patient management |
| Q98164815 | Biologics and surgical outcomes in Crohn's disease: is there a direct relationship? |
| Q81449901 | Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty |
| Q42244257 | Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. |
| Q47892978 | Complications and Disease Recurrence After Primary Ileocecal Resection in Pediatric Crohn's Disease: A Multicenter Cohort Analysis |
| Q42224687 | Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy |
| Q51735449 | Correlation of CT enteroclysis with surgical pathology in Crohn's disease. |
| Q46152475 | Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis |
| Q43203641 | Crohn's disease as an immunodeficiency |
| Q50996989 | Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome. |
| Q41876389 | Does infliximab increase complications after surgery for inflammatory bowel disease? |
| Q38894023 | Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience |
| Q51773806 | Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients. |
| Q51035165 | Effects of anti-inflammatory therapy on bursting pressure of colonic anastomosis in murine dextran sulfate sodium induced colitis. |
| Q36289418 | Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing |
| Q34564902 | European evidence based consensus on the diagnosis and management of Crohn's disease: current management. |
| Q34025054 | European evidence-based Consensus on the management of ulcerative colitis: Current management |
| Q40141223 | Fistulizing Crohn's disease: Diagnosis and management. |
| Q46382454 | Frequency and risk factors of postoperative recurrence of Crohn's disease after intestinal resection in the Chinese population |
| Q88451349 | Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn's disease patients |
| Q53734811 | How I do it: Side-to-side isoperistaltic strictureplasty for extensive Crohn's disease. |
| Q46275695 | Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study |
| Q47888476 | Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? |
| Q53502151 | Impact of preoperative steroid or immunosuppressant use on short-term outcomes following colectomy in Crohn's disease patients. |
| Q40286920 | Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's Disease |
| Q28079926 | Indications and surgical options for small bowel, large bowel and perianal Crohn's disease |
| Q26745627 | Inflammatory bowel disease surgery in the biologic era |
| Q30502980 | Inflammatory bowel disease: perioperative pharmacological considerations |
| Q42265793 | Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis |
| Q45121206 | Infliximab and complications after colectomy in patients with ulcerative colitis |
| Q51412257 | Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. |
| Q37206539 | Infliximab in Crohn's disease: a look at the (not so distant) future |
| Q33597698 | Infliximab's influence on anastomotic strength and degree of inflammation in intestinal surgery in a rabbit model. |
| Q46074566 | Influence of adalimumab treatment on anastomotic strength, degree of inflammation, and collagen formation: an experimental study on the small intestine of rabbits |
| Q36653917 | Insights in immunomodulatory therapies for ulcerative colitis and Crohn's disease |
| Q81761719 | Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome |
| Q57125085 | Laparoscopic surgery for recurrent ileocolic Crohn's disease |
| Q37875963 | Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications. |
| Q38098574 | Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease |
| Q36171733 | Methods to avoid infections in patients with inflammatory bowel disease |
| Q40462673 | New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. |
| Q90746410 | Novel Approaches to Ileocolic and Perianal Fistulising Crohn's Disease |
| Q41429830 | Oversewing staple lines to prevent anastomotic complications in primary ileocolic resections for Crohn's disease |
| Q38990782 | Patient optimization for surgery relating to Crohn's disease |
| Q87901871 | Pediatric Crohn's Disease |
| Q38564693 | Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. |
| Q36940448 | Perioperative Considerations in Crohn Disease and Ulcerative Colitis |
| Q41990775 | Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy |
| Q37792862 | Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease |
| Q37889836 | Perioperative complications in inflammatory bowel disease |
| Q92888132 | Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn's disease: analysis from the PRACTICROHN study |
| Q37254250 | Perioperative management of medications used in the treatment of rheumatoid arthritis |
| Q37776736 | Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders |
| Q53741447 | Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. |
| Q38635824 | Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era". |
| Q38563075 | Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease. |
| Q38791996 | Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis |
| Q42669656 | Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study |
| Q80106777 | Postoperative complications have little influence on long-term quality of life in Crohn's patients |
| Q38691879 | Postoperative course of laparoscopic subtotal colectomy is affected by prolonged preoperative anti-TNF therapy in patients with acute colitis complicating inflammatory bowel disease. |
| Q84382277 | Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease |
| Q48102910 | Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations |
| Q44775146 | Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. |
| Q53163901 | Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. |
| Q47110711 | Preoperative hypoalbuminemia is associated with an increased risk for intra-abdominal septic complications after primary anastomosis for Crohn's disease |
| Q57122251 | Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis |
| Q82673803 | Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study |
| Q37008092 | Preoperative optimization of crohn disease |
| Q44776093 | Preoperative risk evaluation of postoperative morbidity in IBD patients--impact of the POSSUM score |
| Q38179380 | Prevention and management of nonhealing perineal wounds |
| Q82037050 | Pyogenic complications of Crohn's disease, evaluation, and management |
| Q38081399 | Recent advances using immunomodulators for inflammatory bowel disease |
| Q43577963 | Refractory inflammatory bowel disease: surgical challenges |
| Q28294134 | Review article: Infliximab therapy for inflammatory bowel disease--seven years on |
| Q27025900 | Review article: optimal preparation for surgery in Crohn's disease |
| Q40811180 | Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis |
| Q37744596 | Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study |
| Q35540491 | Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies |
| Q43058656 | Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease |
| Q36152213 | Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn's disease following immunosuppressive therapy |
| Q48343747 | Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres. |
| Q57124402 | Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn's disease: who is at risk? |
| Q44037625 | Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal |
| Q37907921 | Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence |
| Q38092279 | Spontaneous abdominopelvic abscess as an initial manifestation of Crohn's disease: a retrospective cohort review |
| Q38155663 | Surgery for Crohn's disease and anti-TNF agents: the changing scenario |
| Q46346648 | Surgical Considerations in the Treatment of Small Bowel Crohn's Disease |
| Q33223348 | Surgical management of Crohn's disease in children |
| Q38082565 | Surgical management of IBD--from an open to a laparoscopic approach. |
| Q37668493 | Surgical management of pyogenic complications of Crohn's disease |
| Q57119438 | Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates? |
| Q83308769 | Surgical site infection following surgery for inflammatory bowel disease in patients with clean-contaminated wounds |
| Q37894193 | TNF alpha antagonist therapy and safety monitoring |
| Q39419599 | The Role of Temporary Fecal Diversion |
| Q42263986 | The effect of immune therapy on surgical site infection following Crohn's Disease resection |
| Q54080713 | The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease. |
| Q41630782 | The impact of bacterial DNA translocation on early postoperative outcomes in Crohn's patients undergoing abdominal surgery. |
| Q38193751 | The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review |
| Q37197292 | The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery |
| Q42202561 | The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease |
| Q38087143 | The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis |
| Q39746279 | The surgical options and management of intestinal Crohn's disease |
| Q38820319 | Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients |
| Q37276979 | Timing of surgery in Crohn's disease: a key issue in the management |
| Q42626492 | Total abdominal colectomy for severe ulcerative colitis: does the laparoscopic approach really have benefit? |
| Q26996946 | Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID) |
| Q81795147 | Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients |
| Q26824662 | Use of thiopurines in inflammatory bowel disease |
| Q38085431 | Variation in management of intra-abdominal abscesses in children with Crohn's disease |
| Q80324112 | [Gangrenous pyoderma and enterocutaneous fistulas after ileal pouch-anal anastomosis] |
Search more.